Progerias and anticipative diseases

• Autorzy: Madej J.A.
• Języki publikacji: EN

Abstrakty

EN

Progerias or senescence syndromes are inherited diseases which develop during childhood and resemble an accelerated in time aging of a mature body. The few progeria types which have been described, i.e. Werner’s syndrome, the syndrome of Hutchinson-Gilford, Cochainer’s syndrome, Down’s syndrome and ataxia teleangiectasia, reflect molecular defects in the repair of DNA. Recognition of etiopathogenesis and clinics of progeria would provide a chance for early detection of the diseases, e.g. in the prenatal period, as well as its more effective treatment. This, perhaps, may provide one of the keys for the recognition of the natural, extremely complex process of body senescence. Anticipative diseases, in turn, represent diseases of children which in their development outpace, even by a few years, and manifest a more acute course, than the same disease noted in the parents. The diseases result from unstable tandem trinucleotide repeats (TREDs). Diseases of this type include myotoic dystrophy 1 (DM1), Huntington’s disease, syndrome of fragile X chromosome, Alzheimer’s disease, Parkinson’s disease, as well as most probably also chronic myeloproliferative diseases (CMDs), Turner’s syndrome and Klinefelter’s syndrome. An attempt was made to compare progerias and anticipative diseases but the problem is difficult to implement at the current condition of knowledge.

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2012
• Tom: 68
• Numer: 02
• Opis fizyczny: p.67-73,fig.,ref.

Twórcy

autor

Madej J.A.

• Chair of Pathology, Department of Pathomorphology and Forensic Veterinary Medicine, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Science, Norwida 31, 50-375 Wroclaw, Poland

Bibliografia

• 1.Ahmad A., Robinson A. R., Duensing A.: ERCC1 - XPF endonuclease facilittes DNA double - stand break repair. Mol. Cell Biol. 2008, 28, 5082-5092.
• 2.Bridger J. M., Kill I. R.: Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis. Exp. Gerontol. 2004, 39, 717-724.
• 3.Cao H., Hegele R. A.: LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090). J. Hum. Genet. 2003, 4, 271-274.
• 4.Chen L., Lee I., Kudlow B. A., Dos Santos H. G., Sletvold O., Shafeghati Y., Botha E. G., Garg A., Hanson N. B., Martin G. M.: LMNA mutations in atypical Werner's syndrome. Lancet 2003, 362, 440-445.
• 5.Elsler W. P., Wolfe M.: A portrait Alzheimer secretases - new features and familiar faces. Science 2001, 293, 1449-1452.
• 6.Eriksson M., Brown W. T., Gordon L. B.: Recurrent de novo point mutations in lamin a causa Hutchinson-Gilford progeria syndrome. Nature 2003, 423, 293-298.
• 7.Fong I. G., Frost D., Meta M., Qiao X., Yang S. H., Coffinier C., Young S. G.: A protein farnesyltranferase inhibitor ameliorates disease in a mouse model of progeria. Science 2006, 31, 1621-1623.
• 8.Gordon I. B., Harten I. A., Patti M. E., Lichtenstein A. H.: Reduced adiponectin and HDL cholesterol without elevated C-reactive protein: clues to the biology of premature atherosclerosis in Hutchison-Gilford progeria syndrome. J. Pediatr. 2005, 146, 336-341.
• 9.Horwitz M., Goode E. L., Jarvik G. P.: Anticipation in familial leukemia. Am. J. Hum. Genet. 1996, 59, 990-998.
• 10.Izbeki F., Asuzu D. T., Lorincz A., Bardsley M. R., Popko L. N., Choi K. M., Young D. L., Hayashi Y., Linden D. R., Kuroo M., Farruga G., Ordog T.: Loss of Kitlow progenitors, reduced stem cell factor and high oxidative stress underlie gastrin dysfunction in progeric mice. J. Physiol. 2010, 15, 3101-3117.
• 11.Jin P., Warren S. T.: Understanding the molecular basis of fragile X syndrome. Hum. Mol. Genet. 2000, 9, 901-907.
• 12.Kawiak J., Zabel M. (red.): Seminaria z cytofizjologii. Wyd Med Urban&Partner, Wrocław 2002.
• 13.Kumar W., Cotran R., Robbins S.: Robbins Patologia. Elsevier, Urban&Partner, Warszawa 2007.
• 14.Lucking C. B., Brice A.: Alpha - synuclein and Parkinson's disease. Cell Mol. Life Sci. 2000, 5, 1894-1992.
• 15.Marino G., Fermandez A. F., Lopez-Otin G.: Autophagy and aging: lessons from progeria models. Adv. Exp. Med. Biol. 2010, 694, 61-68.
• 16.Merideth M. A., Gordon L. B., Clauss S., Sachdev V., Smith A. C., Perry M. B., Brewer C. C., Zalewski C., Kim H. J., Solomon B.: Phenotype and course of Hutchinson-Gilford progeria syndrome. N. Engl. J. Med. 2008, 358, 592-604.
• 17.Nam V., Hyoung-Yeon S., Robinson A., Sowa G., Bentley D., Taylor L., Studer R., Usas A., Huard J., Watkins S. C., Lee J., Coehlo P., Wang D., Loppin M., Robbins P. D., Niedernhofer L. J., Kang J.: Accelerated aging of intervertebral disco in a mouse model of progeria. J. Orthop. Res. 2010, 28, 1600-1607.
• 18.Niedernhofer L. J., Robbins P. D.: Signaling mechanizm involved in the responce to genotoxic stress and regulating lifespan. Int. J. Biochem. Cell Biol. 2008, 40, 176-180.
• 19.Pietrzak J. J.: Postêpy w genetyce w 2003 roku. Med. Prak. Ped. 2004, 2, 1-5.
• 20.Ranke M. B., Saenger P.: Turner syndrome. Lancet 2001, 358, 309-315.
• 21.Rumi E., Passamonit F., Della Porta M. G., Elena C., Arcaini L., Vanelli L., Del Curto C., Pietra D., Boveri E., Pascutto C., Cazzola M., Lazzarino M.: Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation. J. Clin. Oncol. 2007, 25, 5630-5635.
• 22.Sahin E., DePinho R. A.: Linking functional decline of telomeres, mitochondria nad stem cells during ageing. Nature 2010, 464, 520-528.
• 23.Smyth C. M., Bremmer W. J.: Klinefelter syndrome. Arch. Inter. Med. 1998, 158, 1309-1317.
• 24.Towers P. R., Leseure P., Badan D., Malek J. A., Duarte J., Jones E., Davies K. E., Segalat L., Sattelle D. B.: Gene expression profiling studies on Caenorhabditis elegans dystrophin mutations dys-1 (ex-35) and dys-1 (cx-18). Genomics 2006, 88, 642-649.
• 25.Toyokuni S.: Reactive oxygen species - induced molecular damage and its application in pathology. Path. Int. 1999, 49, 91-96.
• 26.Wang Y., Panteleyev A. A., Owens D. M., Djabali K., Stewart C. L., Worman H. J.: Epidermal expression of the truncated prolamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin. Hum. Mol. Genet. 2008, 17, 2357-2369.
• 27.Worman H. J., Ostlund C., Wang Y.: Diseases of the nuclear envelope. Cold. Spring. Harb. Perspect. Biol. 2010, 2, 1-15.
• 28.Wójcik C., Wójcik M.: Niebiałkowe inhibitory kinaz zależnych od cyklin. Post. Biol. Kom. 2000, 27, 377-378.
• 29.Wu Y., Suhasini A. N., Brosh R. M.: Wilcome the family of FANCJ - like helicases to the bloch of genome stability maintenance proteins. Cell Mol. Life Sci. 2000, 66, 1209-1222.
• 30.Verstraeten V. L., Broers J. L. V., Steensel M. A. M., Zinn-Justin S., Ramaekers F. C. S., Steijlen P. M., Kamps M., Kuijers H. J. H., Merckx D., Smeets H. J. M.: Compound heterozygosity for mutations in LMNA causes a progeria syndrome with hout prolamin A accumulation. Hum. Mol. Gent. 2006, 15, 2509-2522.
• 31.Vonsattel J. P. G., DiFiglia M.: Huntington disease. J. Neuropathol. Exp. Neurol. 1998, 57, 369-375.
• 32.Young S. G., Fong I. G., Michaelis S.: Prelamin A, Zmpste24, misshapen cell nuclei, and progeria - New evidence suggesting that proteinn farnesylation could be important for disease pathogenesis. J. Lipid. Res. 2005, 46, 2531-2558.
• 33.Yulle M., Houlston R. S., Catovsky D.: Anticipation in familial chronic lymphocytic leukemia. Leukemia 1998, 12, 1696-1698.

Uwagi

Rekord w opracowaniu